These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 188797)

  • 1. Broad-spectrum derivatives of polymyxin B and colistin.
    Witzke NM; Heding H
    J Antibiot (Tokyo); 1976 Dec; 29(12):1349-50. PubMed ID: 188797
    [No Abstract]   [Full Text] [Related]  

  • 2. The activity of polymyxins against dense populations of Escherichia coli.
    Greenwood D
    J Gen Microbiol; 1975 Nov; 91(1):110-8. PubMed ID: 172601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activity of polymyxins against Escherichia coli in an in-vitro model of the urinary bladder.
    Greenwood D; O'Grady F
    J Med Microbiol; 1977 May; 10(2):255-9. PubMed ID: 192891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of the Individual Major Components of Polymyxin B and Colistin in Rats.
    Sivanesan S; Roberts K; Wang J; Chea SE; Thompson PE; Li J; Nation RL; Velkov T
    J Nat Prod; 2017 Jan; 80(1):225-229. PubMed ID: 28080060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyxin B, colistin, and sodium colistimethate.
    Horton J; Pankey GA
    Med Clin North Am; 1982 Jan; 66(1):135-42. PubMed ID: 6278236
    [No Abstract]   [Full Text] [Related]  

  • 6. The susceptibility of enteropathogenic and non-enteropathogenic porcine Escherichia coli strains to polymyxins and other antibiotics.
    Larsen JL; Søgaard H
    Nord Vet Med; 1981; 33(9-11):393-402. PubMed ID: 6276857
    [No Abstract]   [Full Text] [Related]  

  • 7. Polymyxin derivatives as broad-spectrum antibiotic agents.
    Su M; Wang M; Hong Y; Nimmagadda A; Shen N; Shi Y; Gao R; Zhang E; Cao C; Cai J
    Chem Commun (Camb); 2019 Oct; 55(87):13104-13107. PubMed ID: 31612170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Rapid Polymyxin NP test for detection of colistin susceptibility in Enterobacteriaceae isolated from Thai patients.
    Yainoy S; Hiranphan M; Phuadraksa T; Eiamphungporn W; Tiengrim S; Thamlikitkul V
    Diagn Microbiol Infect Dis; 2018 Oct; 92(2):102-106. PubMed ID: 29884562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the binding of gram-negative bacterial endotoxin by polymyxin B sulphate, colistin sulphate and colistin sulphomethate sodium.
    Rogers MJ; Cohen J
    Infection; 1986; 14(2):79-81. PubMed ID: 3011678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baird-Parker medium supplemented with acriflavine, polymyxins and sulphonamide for the selective isolation of Staphylococcus aureus from heavily contaminated materials.
    Devriese LA
    J Appl Bacteriol; 1981 Apr; 50(2):351-7. PubMed ID: 6265423
    [No Abstract]   [Full Text] [Related]  

  • 11. Cross-resistance to human cationic antimicrobial peptides and to polymyxins mediated by the plasmid-encoded MCR-1?
    Dobias J; Poirel L; Nordmann P
    Clin Microbiol Infect; 2017 Sep; 23(9):676.e1-676.e5. PubMed ID: 28344161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity studies on polymyxin derivatives carrying three positive charges only reveal a new class of compounds with strong antibacterial activity.
    Vaara M; Vaara T; Tyrrell JM
    Peptides; 2017 May; 91():8-12. PubMed ID: 28300674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased colistin resistance upon acquisition of the plasmid-mediated mcr-1 gene in Escherichia coli isolates with chromosomally encoded reduced susceptibility to polymyxins.
    Jayol A; Nordmann P; André C; Dubois V; Poirel L
    Int J Antimicrob Agents; 2017 Sep; 50(3):503-504. PubMed ID: 28729123
    [No Abstract]   [Full Text] [Related]  

  • 14. Electron microscopic studies on mode of action of polymyxin.
    Koike M; Iida K; Matsuo T
    J Bacteriol; 1969 Jan; 97(1):448-52. PubMed ID: 4303542
    [No Abstract]   [Full Text] [Related]  

  • 15. Synergism of the antimicrobial agents miconazole, bacitracin and polymyxin B.
    Cornelissen F; Van den Bossche H
    Chemotherapy; 1983; 29(6):419-27. PubMed ID: 6317296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Toxicity of Polymyxins in Human Lung Epithelial Cells.
    Ahmed MU; Velkov T; Lin YW; Yun B; Nowell CJ; Zhou F; Zhou QT; Chan K; Azad MAK; Li J
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semi-synthesis of polymyxin B (2-10) and colistin (2-10) analogs employing the Trichloroethoxycarbonyl (Troc) group for side chain protection of alpha,gamma-diaminobutyric acid residues.
    Okimura K; Ohki K; Sato Y; Ohnishi K; Sakura N
    Chem Pharm Bull (Tokyo); 2007 Dec; 55(12):1724-30. PubMed ID: 18057747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of polymyxin B and E (colistin) on blood coagulation, thrombocyte function, and fibrin structure (author's transl)].
    Klingemann HG; Egbring R; Kaffarnik H
    Arzneimittelforschung; 1980; 30(10):1719-21. PubMed ID: 6254544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Polymyxin NP test for the detection of polymyxin resistance mediated by the mcr-1/mcr-2 genes.
    Poirel L; Larpin Y; Dobias J; Stephan R; Decousser JW; Madec JY; Nordmann P
    Diagn Microbiol Infect Dis; 2018 Jan; 90(1):7-10. PubMed ID: 29146285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule adjuvants that suppress both chromosomal and mcr-1 encoded colistin-resistance and amplify colistin efficacy in polymyxin-susceptible bacteria.
    Barker WT; Martin SE; Chandler CE; Nguyen TV; Harris TL; Goodell C; Melander RJ; Doi Y; Ernst RK; Melander C
    Bioorg Med Chem; 2017 Oct; 25(20):5749-5753. PubMed ID: 28958847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.